List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 895 studies with search of: HCV
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Conditions: HCV Infection;   Liver Transplantation
Interventions: Biological: MBL-HCV1;   Other: 0.9% Sodium chloride Placebo
2 Completed Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
Condition: Healthy
Intervention: Biological: MBL-HCV1
3 Active, not recruiting Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
4 Recruiting Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C
Condition: Hepatitis C
Interventions: Drug: interferon alfa-2b;   Drug: peginterferon alfa-2b;   Drug: ribavirin, USP;   Device: external drug infusion pump
5 Recruiting Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
6 Recruiting Safety and Effectiveness of Treatment With Pioglitazone Prior to Peginterferon and Ribavirin Therapy for Hepatitis C Virus (HCV) Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin
7 Recruiting Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
8 Recruiting Safety Study to Investigate PSI-7977 in Combination With SOC in Treatment-Naïve HCV Patients With Chronic Hepatitis C Virus(HCV) Infection
Condition: Hepatitis C Virus
Interventions: Drug: PSI-7977 and SOC (PEG-IFN and RBV);   Drug: PSI-7977
9 Completed Chiron Corp HCV E1/E2 Vaccine
Condition: Hepatitis C
Interventions: Biological: HCV E1E2/MF59;   Drug: Placebo
10 Recruiting Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
11 Recruiting Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Conditions: HIV;   Hepatitis C;   Infections
Intervention: Drug: Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)
12 Active, not recruiting Improving Hepatitis C Treatment in Injection Drug Users
Conditions: Hepatitis C;   Liver Diseases;   Drug Abuse;   Alcoholism
Interventions: Drug: Pegylated Interferon and Ribavirin;   Behavioral: Psychosocial;   Behavioral: On-site (MMT Clinic) HCV evaluation and treatment;   Behavioral: Off-site HCV evaluation and treatment
13 Withdrawn TG4040 in Patients With Chronic HCV
Condition: Hepatitis C
Interventions: Drug: Placebo;   Biological: TG4040
14 Completed A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
Condition: Hepatitis C, Chronic
Interventions: Drug: HCV polymerase inhibitor pro-drug;   Drug: PEGASYS;   Drug: Copegus
15 Recruiting Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b
16 Completed A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects
Condition: Hepatitis C
Interventions: Drug: HCV 796;   Drug: Peg-Intron;   Drug: REBETOL
17 Recruiting Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
18 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
19 Completed CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
Condition: Hepatitis, Chronic Active
Interventions: Drug: CPG10101;   Drug: Control
20 Completed A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: RO5024048;   Drug: danoprevir

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services